GINA I | GINAII | GINA III | GINA IV | Total | |
---|---|---|---|---|---|
(n = 5) | (n = 20) | (n = 22) | (n = 10) | (n = 57) | |
Combined LABA with steroid | 80.0% | 57.9% | 19.1% | 30.0% | 38.6% |
ICS | 60.0% | 52.6% | 42.9% | 70.0% | 50.9% |
Short acting bronchodilator | 60.0% | 36.8% | 71.4% | 90.0% | 59.7% |
leukotriene receptor antagonist | 60.0% | 42.1% | 23.8% | 40.0% | 35.1% |
Antibiotics | 40.0% | 36.8% | 52.4% | 70.0% | 47.4% |
Expectorants | 20.0% | 21.1% | 28.6% | 50.0% | 28.1% |
Chinese traditional medicine | 20.0% | 5.3% | 14.3% | 10.0% | 10.5% |
Antitussive | 20.0% | 10.5% | 9.5% | 0.0% | 8.8% |
Combined ≥2 bronchodilators | 0.0% | 31.6% | 4.8% | 60.0% | 24.6% |
Oral corticosteroid | 0.0% | 31.6% | 28.6% | 30.0% | 26.3% |